COVID-19 has heavily affected all our lives and how our health service is able to treat patients. Globally this has had a massive impact on Nasendoscopy procedures. For instance, in 2018, about 500,000 Nasendoscopies were performed in the UK, however, figures during the first peak of COVID-19 suggested that only 8% of the projected Nasendoscopies were able to take place in 2020.

There is a large risk to both ENT Surgeons and Speech & Language Therapists whilst carrying out a Nasendoscopy procedure and the Clinician is at significantly higher levels of contracting COVID-19. The SNAP, Endoscope Guide aims to provide better safety and care for both the Patient and Clinician.

The device ensures safe passage of a Nasendoscopy through a Surgical Mask, creating an aperture for the Endoscope to pass through into the Nasal Cavity. This means that any coughs, splutters, or sneezes throughout the procedure are caught in the mask, which is easily disposed of after use.

DTR Medical and endoscope-i have collaborated in the development of the essential product and helping to bring it to market. This innovative device will enable ENT Clinicians and Speech & Language Therapists to return to Nasendoscopies. This procedure is critical in the diagnosis of Head and Neck Cancer, by reducing COVID-19 risks for the healthcare professional.

Join us for a joint webinar on Wednesday, February 24 to find out how you can continue Nasendoscopy procedures throughout the Coronavirus pandemic with SNAP.

Sign-up before Wednesday 10th February to receive a free SNAP sample for the webinar.

To register for the free webinar, follow the link here: https://www.mediwales.com/event/mediwales-dtr-medical-continuing-ent-diagnosis-throughout-covid-19-safely/.

For more information, contact marketing@dtrmedical.com.